Sep 30

QP 38 - Lung Quick Pitch: Oligometastatic and Oligoprogressive NSCLC

1226 - Feasibility of Aumolertinib followed by SRT in EGFR+ NSCLC Patients with Intracranial Oligo-Progression: A Phase II, Prospective Study

08:20am - 08:25am ET

Presenter(s)

Jiayan Chen, MD - Fudan University Shanghai Cancer Center, Shanghai, Shanghai